Literature DB >> 18277145

Focal segmental glomerulosclerosis: recent advances.

Martin R Pollak1.   

Abstract

PURPOSE OF REVIEW: Focal segmental glomerulosclerosis is a significant and growing cause of chronic kidney disease and nephrotic syndrome in adults and children. RECENT
FINDINGS: The last year has seen continued progress in understanding podocyte biology, mechanisms of podocyte dysfunction, and its contribution to proteinuria and focal segmental glomerulosclerosis.
SUMMARY: A number of studies have helped to elucidate the mechanisms of slit-diaphragm-mediated signaling to the podocyte cytoskeleton. Advances in treatment continue to lag behind advances in understanding focal segmental glomerulosclerosis disease biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18277145     DOI: 10.1097/MNH.0b013e3282f5dbe4

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  19 in total

1.  Familial collapsing focal segmental glomerulosclerosis.

Authors:  V Liakopoulos; A Huerta; S Cohen; M R Pollak; R A Sirota; K Superdock; G B Appel
Journal:  Clin Nephrol       Date:  2011-04       Impact factor: 0.975

2.  TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.

Authors:  Martin Bitzan; Sima Babayeva; Anil Vasudevan; Paul Goodyer; Elena Torban
Journal:  Pediatr Nephrol       Date:  2012-04-27       Impact factor: 3.714

3.  MYO1E mutations and childhood familial focal segmental glomerulosclerosis.

Authors:  Caterina Mele; Paraskevas Iatropoulos; Roberta Donadelli; Andrea Calabria; Ramona Maranta; Paola Cassis; Simona Buelli; Susanna Tomasoni; Rossella Piras; Mira Krendel; Serena Bettoni; Marina Morigi; Massimo Delledonne; Carmine Pecoraro; Isabella Abbate; Maria Rosaria Capobianchi; Friedhelm Hildebrandt; Edgar Otto; Franz Schaefer; Fabio Macciardi; Fatih Ozaltin; Sevinc Emre; Tulin Ibsirlioglu; Ariela Benigni; Giuseppe Remuzzi; Marina Noris
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

Review 4.  Susceptibility genes in common complex kidney disease.

Authors:  Jasmin Divers; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

Review 5.  Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection.

Authors:  Marcus G Pezzolesi; Jan Skupien; Josyf C Mychaleckyj; James H Warram; Andrzej S Krolewski
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

6.  ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1.

Authors:  Akihiro Shimizu; Jianyong Zhong; Yoichi Miyazaki; Tatsuo Hosoya; Iekuni Ichikawa; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2012-03-15       Impact factor: 5.992

7.  Alpha-actinin-4 and CLP36 protein deficiencies contribute to podocyte defects in multiple human glomerulopathies.

Authors:  Zhongmin Liu; Simone Monika Blattner; Yizeng Tu; Robert Tisherman; James H Wang; Maria Pia Rastaldi; Matthias Kretzler; Chuanyue Wu
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

8.  Keap1 inhibition attenuates glomerulosclerosis.

Authors:  Yoichi Miyazaki; Akihiro Shimizu; Ira Pastan; Keiko Taguchi; Eriko Naganuma; Takafumi Suzuki; Tatsuo Hosoya; Takashi Yokoo; Akihiko Saito; Toshio Miyata; Masayuki Yamamoto; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2014-02-11       Impact factor: 5.992

9.  Transforming growth factor beta and excess burden of renal disease.

Authors:  Phyllis August; Vijay Sharma; Ruchuang Ding; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

Review 10.  Renal toxicity of targeted therapies.

Authors:  Ronan J Kelly; Bertrand Billemont; Olivier Rixe
Journal:  Target Oncol       Date:  2009-05-06       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.